Actein Antagonizes Oral Squamous Cell Carcinoma Proliferation through Activating FoxO1

Conclusions: Our findings demonstrated that actein could be a strong anti-OSCC candidate. Further evaluations of its safety and effectiveness are necessary before it can be considered for clinical use.Pharmacology
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research